Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The main objective of the APW-RSV II clinical trial is to evaluate if the addition of
azithromycin to routine bronchiolitis care, among infants hospitalized with RSV
bronchiolitis, reduces the occurrence of recurrent wheeze during the preschool years.